| Mar 3, 2026 | Ayar Labs | $500.0M Series E | Gabe Cahill | 1789 Capital, Alchip, AMD Ventures, ARK Invest, Insight Partners, MediaTek, NVIDIA, Sequoia Global Equities |
| Feb 18, 2026 | Xai | $3.0B Series E | Tareq Amin | Baron Capital Group, Cisco Investments, Fidelity Management & Research Company, MGX, Jensen Huang, Stepstone Group, Antonio Gracias |
| Feb 12, 2026 | Anthropic | $30.0B Series G | Coatue, D. E. Shaw Ventures, Dragoneer Investment Group, Founders Fund, GIC, ICONIQ Growth, MGX | Accel, Addition, Altimeter, AMP PBC, Appaloosa, Baillie Gifford, Bessemer Venture Partners, BlackRock, Blackstone, D1 Capital Partners, Falcon Edge Capital, Fidelity Management & Research Company, General Catalyst, Goldman Sachs, Greenoaks Capital, Insight Partners, Jane Street, J.P. Morgan, Lightspeed Venture Partners, Menlo Ventures, Morgan Stanley, NX1 Capital, Sands Capital, Sequoia Capital, Temasek, TPG, Whale Rock Capital, XN |
| Feb 12, 2026 | Anthropic | $30.0B Series G | Coatue, D. E. Shaw & CO., Dragoneer Investment Group, Founders Fund, GIC, ICONIQ Capital, MGX | Accel, Addition, Alpha Wave Global, Altimeter Capital, AMP PBC, Appaloosa Management, Baillie Gifford, Bessemer Venture Partners, BlackRock, Blackstone, D1 Capital Partners, Fidelity, General Catalyst, Goldman Sachs Alternatives, Greenoaks Capital, Insight Partners, Jane Street Capital, JP Morgan Chase, Lightspeed Venture Partners, Menlo Ventures, Microsoft, Morgan Stanley Investment Management, NVIDIA, NX1 Capital, Sands Capital, Sequoia Capital, Temasek Holdings, TowerBrook Capital Partners, TPG, Whale Rock Capital Management, XN |
| Feb 12, 2026 | Axiom Space | $350.0M Venture Round | Qatar Investment Authority, Type ONE Ventures | 1789 Capital, 4IG, KAM Ghaffarian, LuminArx Capital Management LP |
| Feb 11, 2026 | Apptronik | $520.0M Series A | B Capital, Google, Mercedes Benz Group AG | AT&T Ventures, John Deere, Peak 6, Scrum Ventures |
| Feb 9, 2026 | Databricks | $3.0B Debt / Series L | Fidelity Management & Research Company, Insight Partners | Andreessen Horowitz, Barclays, BlackRock, Blackstone, Citi, Coatue, GIC, Glade Brook Capital, Goldman Sachs, J.P. Morgan, MGX, Microsoft, Morgan Stanley, NEA, Neuberger Berman, Ontario Teachers' Pension Plan Board, Robin Hood Ventures, Temasek, Thrive Capital, T. Rowe Price Associates, UBS, Winslow Capital |
| Feb 4, 2026 | Positron | $230.0M Series B | ARENA Private Wealth, Jump Trading, Unless | 1517 Fund, ARM, Atreides Management, DFJ Growth, Flume Ventures, Helena, Resilience Reserve, Valor Equity Partners |
| Feb 3, 2026 | Skyryse | $300.0M Series C | Autopilot | ArrowMark Partners, Atreides Management, BAM Elevate, Baron Capital Group, Durable Capital Partners, Fidelity Management & Research Company, Positive SUM, Rokos Capital Management, Woodline Partners |
| Dec 2, 2025 | Mujin | $233.7M Debt / Series D | Akira Shimada, Qatar Investment Authority | Shoko Chukin Bank, Aozora Bank, Fukuoka Bank, Joyo Bank, Mitsubishi HC Capital Realty, Mizuho Bank, Nagoya Bank, Salesforce Ventures, Sumitomo Mitsui Trust Bank, Upsider Capital, Yokohama Capital |
| Dec 1, 2025 | Akura Medical | $53.0M Series C | Qatar Investment Authority | — |
| Nov 12, 2025 | d-Matrix | $275.0M Matrix - Series C | PER Roman, Temasek, Jeff Huber | EDBI, Industry Ventures, Michael Stewart, Mirae Asset, Nautilus Venture Partners |
| Nov 10, 2025 | Iambic Therapeutics | $100.0M Other Equity | — | Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK Invest, Ascenta Capital, Catalio Capital, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Regeneron Ventures, Sequoia Capital, TAO Capital Partners, Terra Magnum Capital Partners, Wilson Sonsini Goodrich & Rosati |
| Nov 1, 2025 | Synchron | $200.0M Series D | Campbell Murray | ARCH Venture Partners, Khosla Ventures, Presight Capital, PSG, Bezos Expeditions, IN Q TEL, K5 Global, Metis, NTI, Protocol Labs, The National Reconstruction Fund Corporation, BOB Langer |
| Oct 1, 2025 | Kailera Therapeutics | $600.0M Series B | Andrew Kaplan | Bain Capital, Gotham Makker, Michael Gladstone, Adage Capital Management, Atlas Venture, Bain Capital Life Sciences, Invus, Janus Henderson Investors, Perseverance Capital Management, Royalty Pharma, Roderick Wong, Sirona Capital, Surveyor Capital, T. Rowe Price Associates |
| Sep 23, 2025 | Ensoma | $53.0M Other Equity | — | 5AM Ventures, Bill & Melinda Gates Foundation, Catalio Capital, Cormorant Asset Management, Delos Capital, F Prime Capital, Gilead Sciences, Hanwha Impact, Mirae Asset, RTW Investments, Solasta Ventures, SymBiosis, Viking Global Investors |
| Sep 10, 2025 | PsiQuantum | $1.0B Series E | Tony KIM, Temasek | Michael Tolo, 1789 Capital, Adage Capital Management, Macquarie Capital, Morgan Stanley, NVentures, Ribbit Capital, S Ventures, Third Point Ventures, T. Rowe Price Associates, Type ONE Ventures |
| Sep 3, 2025 | Anthropic | $13.0B Series F | Fidelity Management & Research Company, Divesh Makan, Lightspeed Venture Partners | Altimeter, BlackRock, Blackstone, Coatue, D1 Capital Partners, General Atlantic, General Catalyst, GIC, Goldman Sachs, Insight Partners, Jane Street, TPG, T. Rowe Price Associates, WCM, XN |
| Sep 1, 2025 | Ensoma | $53.0M Series U | — | 5AM Ventures, Arix Bioscience, Bioluminescence Ventures, F Prime Capital, Bill & Melinda Gates Foundation, Catalio Capital, Cormorant Asset Management, Delos Capital, Gilead Sciences, Hanwha Impact, Mirae Asset, RTW Investments, Solasta Ventures, SymBiosis, Viking Global Investors |
| Jul 1, 2025 | ARTBIO | $130.0M Series B | B Capital Group, Sofinnova Investments | Alumni Ventures, F Prime Capital, Perceptive Advisors, Third Rock Ventures, VenBio Partners, Adrien Cohen, Jeffrey Tong, Alexandria Venture Investments, F Prime Capital, Omega Funds |
| Jun 1, 2025 | Applied Intuition | $600.0M Series F | Kleiner Perkins, Samir Menon | AngelList, Founder Collective, Greylock, Khosla Ventures, Spark Capital, Aaron Levie, Akshay Kothari, Frederic Kerrest, Howie LIU, Immad Akhund, Jeremy Stoppelman, MAX Mullen, Michael MA, Neha Narkhede, Oliver Cameron, SAM Blond, Elad GIL, ABU Dhabi Investment Council, Mary Meeker, General Catalyst, Greycroft, LUX Capital |
| Jan 1, 2025 | Instabase | $100.0M Series D | Qatar Investment Authority | Kevin Hartz, Addition, Andreessen Horowitz, Balderton Capital, CRV, Global Innovation Fund, Greylock, Hanabi Capital, Innovation Endeavors, LombardStreet Ventures, Mucker Capital, Glenn Solomon, Propeller VC, Dwipal Desai, Frederic Kerrest, Jeff Bezos, ROB Theis |
| Dec 25, 2024 | Xai | $6.0B Series C | — | AMD Ventures, Andreessen Horowitz, BlackRock, Fidelity Management & Research Company, Kingdom Holding, Lightspeed Venture Partners, MGX, Morgan Stanley, NVIDIA, Oman Investment Authority, Sequoia Capital, Valor Equity Partners, VY Capital |
| Jun 18, 2024 | Iambic Therapeutics | $50.0M Series B Extension | Exor Ventures, Ayman Alabdallah | Abingworth, Coatue, Illumina Ventures, Nexus Venture Partners, TAO Capital Partners |
| Sep 1, 2023 | Star Therapeutics | $90.0M Series C | Sofinnova Investments | Foresite Capital, OrbiMed, Sanofi Ventures, Versant Ventures, Westlake Village BioPartners, Agent Capital, Catalio Capital, Cormorant Asset Management, Cowen Healthcare Investments, Vijay Lathi, Nybc Ventures, Matthew Hammond, Amrit Nagpal, Soleus Capital |